Use of synaptotagmin-7 in the diagnosis and treatment of bipolar disorder
US-2023003717-A1 · Jan 5, 2023 · US
This page is not indexed by search engines while we improve data quality.
Patent family 70625351
This patent family groups 1 related publication across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 70625351 |
| Family type | — |
| Earliest priority | Jan 22, 2020 |
| First filing country | US |
| Member publications | 1 |
| Countries | US |
| Representative publication | US2023003717A1 — Use of synaptotagmin-7 in the diagnosis and treatment of bipolar disorder |
Representative publication
Best representative member for this family based on priority and filing country.
US2023003717A1 — Use of synaptotagmin-7 in the diagnosis and treatment of bipolar disorder (published Jan 5, 2023)
Member publications
Related publications in this family.